Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine in allergic airway disease
NCT00779636Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Jul 2003
- Primary completion
- Nov 2004
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in seasonal allergic rhinitis (SAR) and allergic airway disease (AAD) comparing Desloratadine 10 mg with Placebo (2 arms). Primary endpoint: Change in FEV1 averaged over weeks 1 to 4. Started Jul 2003; status: completed.
02
Drugs
desloratadine
03
Conditions
seasonal allergic rhinitis (SAR)allergic airway disease (AAD)
Beyond the preview
Go deeper on NCT00779636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00779636.